The Office of Admissions recruits and matriculates those individuals most likely to enhance the overall health of our local, regional, national and international communities through the development of new knowledge and the provision of exemplary patient care. Each year, the School of Medicine matriculates a group of talented individuals who reflect the growing ethnic and cultural diversity of present day society, drawing on the knowledge and skills of individuals from all segments of society. Learn more about our Vision & Values.
Through innovative identification, recruitment and development programs, the School of Medicine has become recognized for the rich diversity of its student body. The Committee on Admissions has the daunting yet important job of selecting an outstanding entering freshman class each year from a bright, dedicated and diverse pool of applicants. The Committee will admit only those individuals who demonstrate the intellectual curiosity necessary for a lifetime of learning and who the Committee believes will maintain the highest standards of ethical and professional conduct.
Our students are our most prized asset and our dedicated faculty takes great joy and pride in helping each and every one of them develop into our future colleagues in the profession of medicine.
Young Cancer Survivor from Baltimore Helps Celebrate Countdown to Opening of the Maryland Proton Treatment CenterIn October 2015, the Maryland Proton Treatment Center (MPTC) will open its doors to patients. The center will provide an innovative, precise approach to cancer, which targets tumors while minimizing harm to surrounding tissues.
University of Maryland School of Medicine and Malian Ministry of Health begin Human Trials of Experimental Ebola Vaccine in Mali, West AfricaProfessor Myron M. Levine, MD, Director of the Center for Vaccine Development (CVD) at the University of Maryland School of Medicine (UM SOM), and UM SOM Dean E. Albert Reece MD, PhD, MBA, announced today that the CVD, in conjunction with its sister institution, The Center for Vaccine Development of Mali (CVD-Mali) and the Ministry of Health of Mali, have begun a clinical trial in health care workers (and other front-line workers) to evaluate a promising experimental Ebola vaccine.
University of Maryland School of Medicine and Ottawa Heart Insitute Researchers Identify New Pathway Linking the Brain to High Blood PressureNew research by scientists at the University of Maryland School of Medicine (UM SOM) and the Ottawa Heart Institute has uncovered a new pathway by which the brain uses an unusual steroid to control blood pressure. The study, which also suggests new approaches for treating high blood pressure and heart failure, appears today in the journal Public Library of Science (PLOS) One.
Dean Reece says the School of Medicine, and its Center for Vaccine Development, is working with the World Health Organization to Address the Ebola Virus Crisis.
Institute of Human Virology (IHV) Welcomes Renowned Infectious Disease Specialist Dr. Shyamasundaran KottililRobert C. Gallo, MD, director of the Institute of Human Virology (IHV) at the University of Maryland School of Medicine (UM SOM), and UM SOM Dean E. Albert Reece MD, PhD, MBA, announced today that Shyamasundaran Kottilil, MBBS, PhD, a world-renowned expert in infectious disease, has joined the faculty as Co-Director of IHV’s Clinical Research Unit and Associate Director for Clinical Research in the Institute’s Division of Clinical Care and Research.